{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:51:43Z","timestamp":1792324303581,"version":"4.4.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1093\/humrep\/del072","type":"journal-article","created":{"date-parts":[[2006,3,23]],"date-time":"2006-03-23T20:34:25Z","timestamp":1143146065000},"page":"1894-1900","source":"Crossref","is-referenced-by-count":107,"title":["GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study"],"prefix":"10.1093","volume":"21","author":[{"given":"C.","family":"Pirard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Loumaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,23]]},"reference":[{"key":"key\n\t\t\t\t20171012094940_b1","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/14.6.1426","article-title":"Luteal phase and clinical outcome after human menopausal gonadotrophin\/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"14","author":"Albano","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b2","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","article-title":"Non-supplemented luteal phase characteristics following the administration of r-hCG, r-hLH or GnRH agonist to induce final oocyte maturation in in vitro fertilisation patients","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012094940_b3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/13.4.811","article-title":"Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal GnRH analogue (buserelin): effective minimal dose","volume":"13","author":"Buckett","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0301-2115(98)00109-2","article-title":"Triptorelin acetate administration in early pregnancy: case reports and review of the literature","volume":"80","author":"Chardonnens","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012094940_b5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0015-0282(16)57557-8","article-title":"Administration of a GnRH agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline","volume":"63","author":"Elefant","year":"1995","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profile after triggering of final oocyte maturation with GnRH agonist after co-treatment with the GnRH antagonist Ganirelix during ovarian hyperstimulation for in vitro fertilisation","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012094940_b7","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/humrep\/12.11.2557","article-title":"Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle","volume":"12","author":"Gartner","year":"1997","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/oxfordjournals.humrep.a137671","article-title":"Impaired corpus luteum and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone","volume":"7","author":"Golan","year":"1992","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0015-0282(03)00663-0","article-title":"Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists","volume":"80","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b12","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0015-0282(16)47062-7","article-title":"Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinising hormone-releasing hormone agonist at different days after the mid-cycle luteinising hormone surge","volume":"39","author":"Lemay","year":"1983","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2001-13909","article-title":"On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation","volume":"19","author":"Licht","year":"2001","journal-title":"Semin Reprod Med"},{"key":"key\n\t\t\t\t20171012094940_b15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/oxfordjournals.humrep.a137105","article-title":"The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer","volume":"5","author":"Loumaye","year":"1990","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0015-0282(16)48256-7","article-title":"Immunoreactive relaxin surge in the peritoneal fluid of women during the mid-luteal phase","volume":"42","author":"Loumaye","year":"1984","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b17","first-page":"101","article-title":"Impact of ovarian hyperstimulation on the luteal phase","volume":"55","author":"Macklon","year":"2000","journal-title":"J Reprod Fertil"},{"key":"key\n\t\t\t\t20171012094940_b18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0015-0282(16)58404-0","article-title":"Triggering of ovulation by a GnRH agonist in patients pretreated with a GnRH antagonist","volume":"66","author":"Olivennes","year":"1996","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/deh830","article-title":"GnRH agonist as a novel luteal support: results of a randomised, parallel group, feasibility study using intra-nasal administration of buserelin","volume":"20","author":"Pirard","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b20","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","article-title":"Luteal support in infertility treatment: a meta-analysis of the randomized trials","volume":"17","author":"Pritts","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0303-7207(01)00694-3","article-title":"Consequences of targeted inactivation of LH receptors","volume":"187","author":"Rao","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t20171012094940_b22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0015-0282(16)53361-5","article-title":"Midluteal gonadodtropin-releasing hormone analog administration in early pregnancy","volume":"53","author":"Ron-El","year":"1990","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/oxfordjournals.humrep.a137324","article-title":"The influence of inadvertent intranasal buserelin administration in early pregnancy","volume":"6","author":"Smitz","year":"1991","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/oxfordjournals.humrep.a137871","article-title":"A prospective randomized study on oestradiol valerate supplementation in addition to intra-vaginal micronized progesterone in buserelin and hMG induced superovulation","volume":"8","author":"Smitz","year":"1993","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/107155760100800603","article-title":"Gonadotropins and the uterus: is there a gonad-independent pathway?","volume":"8","author":"Stewart","year":"2001","journal-title":"J Soc Gynecol Investig"},{"key":"key\n\t\t\t\t20171012094940_b26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(01)00134-6","article-title":"Impact of ovarian stimulation on corpus luteum function and embryonic implantation","volume":"55","author":"Tavaniotou","year":"2002","journal-title":"J Reprod Immunol"},{"key":"key\n\t\t\t\t20171012094940_b27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(01)03265-4","article-title":"Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist","volume":"77","author":"Tavaniotou","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-6483(10)61729-4","article-title":"Luteinizing hormone affects uterine receptivity independently of ovarian function","volume":"7","author":"Tesarik","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012094940_b29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/deh235","article-title":"Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation","volume":"19","author":"Tesarik","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012094940_b30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0015-0282(01)02854-0","article-title":"Comparison of G1.2\/G2.2 and Sydney IVF cleavage\/blastocyst sequential media for culture of human embryos: a prospective, randomized, comparative study","volume":"76","author":"Van Langendonckt","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0015-0282(16)56396-1","article-title":"GnRH agonist administration in early human pregnancy is associated with normal outcomes","volume":"60","author":"Wilshire","year":"1993","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012094940_b32","first-page":"273","article-title":"The human menstrual cycle: neuroendocrine regulation","volume-title":"Reproductive Endocrinology","author":"Yen","year":"1991","edition":"3rd edn."},{"key":"key\n\t\t\t\t20171012094940_b33","first-page":"587","article-title":"GnRH agonist exposure during the first trimester of pregnancy","volume":"81","author":"Young","year":"1993","journal-title":"Obstet Gynecol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/21\/7\/1894\/9680925\/del072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:12:14Z","timestamp":1507803134000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/21\/7\/1894\/2938544\/GnRH-agonist-as-luteal-phase-support-in-assisted"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,23]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,23]]},"published-print":{"date-parts":[[2006,7]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/del072","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,23]]}}}